WolverHeme Happy Hour

A podcast by Bernard Marini, Anthony Perissinotti, et al.

31 Episodes

  1. Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates

    Published: 12/24/2024
  2. A Bunch of ASHholes Discuss Myeloma Abstracts

    Published: 11/16/2024
  3. Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

    Published: 11/8/2024
  4. Episode 27: Mantle Cell Masterclass with Tycel Phillips

    Published: 10/10/2024
  5. Houston, we don't have a problem... with APOLLO

    Published: 8/28/2024
  6. From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment

    Published: 6/13/2024
  7. Episode 24: Myeloma Madness with the Myeloma Man

    Published: 4/17/2024
  8. Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

    Published: 1/25/2024
  9. LymphOMG: Pouring Over Lymphoma Abstracts from ASH

    Published: 12/29/2023
  10. AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy

    Published: 12/19/2023
  11. ASH Pregaming - Myeloma Madness with Manni and Papa Heme

    Published: 12/1/2023
  12. AML Maintenance Part 2: a metaMORPHOsis?

    Published: 11/8/2023
  13. AML Maintenance Part 1: Set Your QUAZARs to Stun

    Published: 10/25/2023
  14. Episode 17: The Hemophilia Eras Tour

    Published: 8/23/2023
  15. Common Sense Oncology: Outcomes That Matter

    Published: 8/1/2023
  16. All too well: the reality of leukemia treatment

    Published: 6/8/2023
  17. Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby

    Published: 5/9/2023
  18. Episode 13: You get blinatumomab! You get blinatumomab!

    Published: 2/24/2023
  19. Episode 12: Tinder for T Cells - Bispecifics in DLBCL

    Published: 2/8/2023
  20. Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon

    Published: 1/21/2023

1 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.